COMPASS Pathways plc (CMPS)
CMPS Stock Price Chart
Explore COMPASS Pathways plc interactive price chart. Choose custom timeframes to analyze CMPS price movements and trends.
CMPS Company Profile
Discover essential business fundamentals and corporate details for COMPASS Pathways plc (CMPS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
18 Sept 2020
Employees
166.00
Website
https://compasspathways.comCEO
Kabir Kumar Nath
Description
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
CMPS Financial Timeline
Browse a chronological timeline of COMPASS Pathways plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is -$0.39.
Earnings released on 13 May 2026
EPS came in at -$0.70 falling short of the estimated -$0.45 by -55.56%.
Earnings released on 24 Mar 2026
EPS came in at -$0.59 falling short of the estimated -$0.41 by -43.90%.
Earnings released on 4 Nov 2025
EPS came in at -$0.38 surpassing the estimated -$0.40 by +5.00%.
Earnings released on 31 Jul 2025
EPS came in at -$0.38 falling short of the estimated -$0.37 by -2.70%.
Earnings released on 8 May 2025
EPS came in at -$0.44 surpassing the estimated -$0.47 by +6.38%.
Earnings released on 27 Feb 2025
EPS came in at -$0.63 falling short of the estimated -$0.62 by -1.61%.
Earnings released on 31 Oct 2024
EPS came in at -$0.56 surpassing the estimated -$0.60 by +6.67%.
Earnings released on 1 Aug 2024
EPS came in at -$0.56 falling short of the estimated -$0.53 by -5.66%.
Earnings released on 8 May 2024
EPS came in at -$0.55 falling short of the estimated -$0.52 by -5.77%.
Earnings released on 29 Feb 2024
EPS came in at -$0.53 falling short of the estimated -$0.37 by -43.24%, while revenue for the quarter reached $3.68m .
Earnings released on 2 Nov 2023
EPS came in at -$0.67 falling short of the estimated -$0.50 by -34.00%.
Earnings released on 3 Aug 2023
EPS came in at -$0.62 surpassing the estimated -$0.69 by +10.14%.
Earnings released on 11 May 2023
EPS came in at -$0.57 surpassing the estimated -$0.73 by +21.92%.
Earnings released on 28 Feb 2023
EPS came in at -$0.73 falling short of the estimated -$0.65 by -12.31%.
Earnings released on 3 Nov 2022
EPS came in at -$0.43 surpassing the estimated -$0.66 by +34.85%.
Earnings released on 4 Aug 2022
EPS came in at -$0.50 surpassing the estimated -$0.61 by +18.03%.
Earnings released on 10 May 2022
EPS came in at -$0.50 surpassing the estimated -$0.68 by +26.47%.
Earnings released on 24 Feb 2022
EPS came in at -$0.61 falling short of the estimated -$0.48 by -27.08%.
Earnings released on 9 Nov 2021
EPS came in at -$0.38 surpassing the estimated -$0.50 by +24.00%.
Earnings released on 11 Aug 2021
EPS came in at -$0.44 falling short of the estimated -$0.33 by -33.33%.
CMPS Stock Performance
Access detailed CMPS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
